|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33.
2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
GLOBOCAN: Global cancer observatory.
Journal, 2022.
|
|
3
|
SEER Cancer Statistics Review. Cancer stat
facts: Lung and bronchus cancer. Journal, 2021.
|
|
4
|
Walters S, Maringe C, Coleman MP, Peake
MD, Butler J, Young N, Bergström S, Hanna L, Jakobsen E, Kölbeck K,
et al: Lung cancer survival and stage at diagnosis in Australia,
Canada, Denmark, Norway, Sweden and the UK: A population-based
study, 2004-2007. Thorax. 68:551–564. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Salhab HA, Fares MY, Khachfe HH and
Khachfe HM: Epidemiological Study of lung cancer incidence in
Lebanon. Medicina (Kaunas). 55(217)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shurrab SA, Al-Badarneh AF, Nassar HI and
Almshnanah AH: Cancer in five countries of the eastern
mediterranean region: Epidemiological trends and risk implications.
Niger J Clin Pract. 25:78–84. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rahal Z, El Nemr S, Sinjab A, Chami H,
Tfayli A and Kadara H: Smoking and lung cancer: A geo-regional
perspective. Front Oncol. 7(194)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Salman R, Amhaz K, Hellani A, Tayara L and
Mourda B: The Epidemiology of Lung Cancer in Lebanon During 2014.
Int J Epidemiol Res. 7:63–67. 2020.
|
|
9
|
Bannister N and Broggio J: Cancer survival
by stage at diagnosis for England (experimental statistics): Adults
diagnosed. 2012, 2013 and 2014 and followed up to 2015. Journal,
2016.
|
|
10
|
National Lung Screening Trial Research
Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom
RM, Gareen IF, Gatsonis C, Marcus PM and Sick JD: Reduced
lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med. 365:395–409. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pinsky PF, Church TR, Izmirlian G and
Kramer BS: The national lung screening trial: Results stratified by
demographics, smoking history, and lung cancer histology. Cancer.
119:3976–3983. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
de Koning HJ, van der Aalst CM, de Jong
PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JWJ, Weenink
C, Yousaf-Khan U, Horeweg N, et al: Reduced lung-cancer mortality
with volume CT screening in a randomized trial. N Engl J Med.
382:503–513. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cainap C, Pop LA, Balacescu O and Cainap
SS: Early diagnosis and screening in lung cancer. Am J Cancer Res.
10:1993–2009. 2020.PubMed/NCBI
|
|
14
|
Dominioni L, Poli A, Mantovani W, Pisani
S, Rotolo N, Paolucci M, Sessa F, Conti V, D'Ambrosio V, Paddeu A
and Imperatori A: Assessment of lung cancer mortality reduction
after chest X-ray screening in smokers: A population-based cohort
study in Varese, Italy. Lung Cancer. 80:50–54. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kim J and Kim KH: Role of chest
radiographs in early lung cancer detection. Transl Lung Cancer Res.
9:522–531. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nakayama T, Baba T, Suzuki T, Sagawa M and
Kaneko M: An evaluation of chest X-ray screening for lung cancer in
gunma prefecture, Japan: A population-based case-control study. Eur
J Cancer. 38:1380–1387. 2002.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kaviani P, Digumarthy SR, Bizzo BC, Reddy
B, Tadepalli M, Putha P, Jagirdar A, Ebrahimian S, Kalra MK and
Dreyer KJ: Performance of a chest radiography AI algorithm for
detection of missed or mislabeled findings: A multicenter study.
Diagnostics (Basel). 12(2086)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hunger T, Wanka-Pail E, Brix G and Griebel
J: Lung cancer screening with low-dose CT in smokers: A systematic
review and meta-analysis. Diagnostics (Basel).
11(1040)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Infante M, Cavuto S, Lutman FR, Passera E,
Chiarenza M, Chiesa G, Brambilla G, Angeli E, Aranzulla G, Chiti A,
et al: Long-term follow-up results of the DANTE trial, a randomized
study of lung cancer screening with spiral computed tomography. Am
J Respir Crit Care Med. 191:1166–1175. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wille MMW, Dirksen A, Ashraf H, Saghir Z,
Bach KS, Brodersen J, Clementsen PF, Hansen H, Larsen KR, Mortensen
J, et al: Results of the randomized danish lung cancer screening
trial with focus on high-risk profiling. Am J Respir Crit Care Med.
193:542–551. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pastorino U, Silva M, Sestini S, Sabia F,
Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G and
Marchianò A: Prolonged lung cancer screening reduced 10-year
mortality in the MILD trial: New confirmation of lung cancer
screening efficacy. Ann Oncol. 30:1162–1169. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Becker N, Motsch E, Trotter A, Heussel CP,
Dienemann H, Schnabel PA, Kauczor HU, Maldonado SG, Miller AB,
Kaaks R and Delorme S: Lung cancer mortality reduction by LDCT
screening-results from the randomized German LUSI trial. Int J
Cancer. 146:1503–1513. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wood DE, Kazerooni EA, Baum SL, Eapen GA,
Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner
RP, et al: Lung cancer screening, version 3.2018, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
16:412–441. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dyer O: US task force recommends extending
lung cancer screenings to over 50s. BMJ. 372(n698)2021.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Mazzone PJ, Silvestri GA, Souter LH,
Caverly TJ, Kanne JP, Katki HA, Wiener RS and Detterbeck FC:
Screening for lung cancer: CHEST guideline and expert panel report.
Chest. 160:e427–e494. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
American Society of Clinical Oncology.
Lung cancer-non-small cell: Screening. 2021 27 January 2022].
Available from: https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/screening.
|
|
27
|
American Lung Association. Is lung cancer
screening right for me? 2021 27 January 2022]. Available from:
https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/saved-by-the-scan/resources/is-lung-cancer-screening-right.
|
|
28
|
Armstrong C: Lung cancer screening
recommendations from the ACCP. Am Fam Physician. 98:688–689.
2018.PubMed/NCBI
|
|
29
|
Canadian Task Force on Preventive Health
Care. Recommendations on screening for lung cancer. CMAJ.
188:425–432. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ordóñez-Mena JM, Schöttker B, Mons U,
Jenab M, Freisling H, Bueno-de-Mesquita B, O'Doherty MG, Scott A,
Kee F, Stricker BH, et al: Quantification of the smoking-associated
cancer risk with rate advancement periods: Meta-analysis of
individual participant data from cohorts of the CHANCES consortium.
BMC Med. 14(62)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bach PB, Kattan MW, Thornquist MD, Kris
MG, Tate RC, Barnett MJ, Hsieh LJ and Begg CB: Variations in lung
cancer risk among smokers. J Natl Cancer Inst. 95:470–478.
2003.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Katki HA, Kovalchik SA, Berg CD, Cheung LC
and Chaturvedi AK: Development and validation of risk models to
select ever-smokers for CT lung cancer screening. JAMA.
315:2300–2311. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ball D: The IASLC multidisciplinary
approach to thoracic oncology. Aurora, CO: International
Association for the Study of Lung Cancer, 2014.
|
|
34
|
McCarthy WJ, Meza R, Jeon J and Moolgavkar
SH: Chapter 6: Lung cancer in never smokers: Epidemiology and risk
prediction models. Risk Anal. 32 (Suppl 1):S69–S84. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Alberg AJ, Wallace K, Silvestri GA and
Brock MV: Invited commentary: The etiology of lung cancer in men
compared with women. Am J Epidemiol. 177:613–616. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Planchard D and Besse B: Lung cancer in
never-smokers. Eur Respir J. 45:1214–1217. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Subramanian J and Govindan R: Lung cancer
in ‘never-smokers’: A unique entity. Oncology (Williston Park).
24:29–35. 2010.PubMed/NCBI
|
|
38
|
Lorenzo Bermejo J and Hemminki K: Familial
lung cancer and aggregation of smoking habits: A simulation of the
effect of shared environmental factors on the familial risk of
cancer. Cancer Epidemiol Biomarkers Prev. 14:1738–1740.
2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bae JM: Modifiable risk factors of lung
cancer in ‘never-smoker’ women. Epidemiol Health.
37(e2015047)2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ministry of Public Health: NCR
tables-counts of cases. Journal, 2016.
|
|
41
|
Jaafar W, Zaherddine V, Hussein F, Saliba
NA and Hayeck N: Poor regulation implications in a low and middle
income country based on PAH source apportionment and cancer risk
assessment. Environ Sci Process Impacts. 23:1986–1996.
2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Waked M, Salameh P and Aoun Z: Water-pipe
(narguile) smokers in Lebanon: A pilot study. East Mediterr Health
J. 15:432–442. 2009.PubMed/NCBI
|
|
43
|
Jawad M, Charide R, Waziry R, Darzi A,
Ballout RA and Akl EA: The prevalence and trends of waterpipe
tobacco smoking: A systematic review. PLoS One.
13(e0192191)2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Warren CW, Lea V, Lee J, Jones NR, Asma S
and McKenna M: Change in tobacco use among 13-15 year olds between
1999 and 2008: Findings from the global youth tobacco survey. Glob
Health Promot. 16 (2 Suppl):S38–S90. 2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Badran M and Laher I: Waterpipe (shisha,
hookah) smoking, oxidative stress and hidden disease potential.
Redox Biol. 34(101455)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Shihadeh A: Investigation of mainstream
smoke aerosol of the argileh water pipe. Food Chem Toxicol.
41:143–152. 2003.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Monn C, Kindler P, Meile A and Brändli O:
Ultrafine particle emissions from waterpipes. Tob Control.
16:390–393. 2007.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Awan KH, Siddiqi K, Patil Sh and Hussain
QA: Assessing the effect of waterpipe smoking on cancer outcome-a
systematic review of current evidence. Asian Pac J Cancer Prev.
18:495–502. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Eissenberg T and Shihadeh A: Waterpipe
tobacco and cigarette smoking: Direct comparison of toxicant
exposure. Am J Prev Med. 37:518–523. 2009.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Henschke CI, Naidich DP, Yankelevitz DF,
McGuinness G, McCauley DI, Smith JP, Libby D, Pasmantier M, Vazquez
M, Koizumi J, et al: Early lung cancer action project: Initial
findings on repeat screenings. Cancer. 92:153–159. 2001.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Swensen SJ, Jett JR, Sloan JA, Midthun DE,
Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel
GR, et al: Screening for lung cancer with low-dose spiral computed
tomography. Am J Respir Crit Care Med. 165:508–513. 2002.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Bou Akl I, K Zgheib N, Matar M, Mukherji
D, Bardus M and Nasr R: Primary care and pulmonary physicians'
knowledge and practice concerning screening for lung cancer in
Lebanon, a middle-income country. Cancer Med. 10:2877–2884.
2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Elias F, Khuri FR, Adib SM, Karam R, Harb
H, Awar M, Zalloua P and Ammar W: Financial burden of cancer drug
treatment in Lebanon. Asian Pac J Cancer Prev. 17:3173–3177.
2016.PubMed/NCBI
|
|
54
|
Bader P, Boisclair D and Ferrence R:
Effects of tobacco taxation and pricing on smoking behavior in high
risk populations: A knowledge synthesis. Int J Environ Res Public
Health. 8:4118–4139. 2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Sibai AM, Iskandarani M, Darzi A, Nakkash
R, Saleh S, Fares S and Hwalla N: Cigarette smoking in a Middle
Eastern country and its association with hospitalisation use: A
nationwide cross-sectional study. BMJ Open.
6(e009881)2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Babb S, Malarcher A, Schauer G, Asman K
and Jamal A: Quitting smoking among adults-United States,
2000-2015. MMWR Morb Mortal Wkly Rep. 65:1457–1464. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
United States Public Health Service Office
of the Surgeon General; National Center for Chronic Disease
Prevention and Health Promotion (US) Office on Smoking and Health:
Smoking cessation: A report of the surgeon general. Chapter 6,
Interventions for smoking cessation and treatments for nicotine
dependence. Washington (DC): US Department of Health and Human
Services, 2020.
|
|
58
|
Knudsen HK, Studts CR and Studts JL: The
implementation of smoking cessation counseling in substance abuse
treatment. J Behav Health Serv Res. 39:28–41. 2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al: Global surveillance of trends in cancer survival
2000-14 (CONCORD-3): Analysis of individual records for 37 513 025
patients diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet. 391:1023–1075. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Cheng TYD, Cramb SM, Baade PD, Youlden DR,
Nwogu C and Reid ME: The international epidemiology of lung cancer:
Latest trends, disparities, and tumor characteristics. J Thorac
Oncol. 11:1653–1671. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer: Apr 5, 2021 (Epub ahead of
print).
|
|
62
|
Johnson DH, Fehrenbacher L, Novotny WF,
Herbst RS, Nemunaitis JJ, Jablons DM, Langer CJ, DeVore RF III,
Gaudreault J, Damico LA, et al: Randomized phase II trial comparing
bevacizumab plus carboplatin and paclitaxel with carboplatin and
paclitaxel alone in previously untreated locally advanced or
metastatic non-small-cell lung cancer. J Clin Oncol. 22:2184–2191.
2004.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Russo C, Walicka M, Caponnetto P, Cibella
F, Maglia M, Alamo A, Campagna D, Frittitta L, Di Mauro M, Caci G,
et al: Efficacy and safety of varenicline for smoking cessation in
patients with type 2 diabetes: A randomized clinical trial. JAMA
Netw Open. 5(e2217709)2022.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Courtney RJ, McRobbie H, Tutka P, Weaver
NA, Petrie D, Mendelsohn CP, Shakeshaft A, Talukder S, Macdonald C,
Thomas D, et al: Effect of cytisine vs varenicline on smoking
cessation: A randomized clinical trial. JAMA. 326:56–64.
2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Corelli RL and Hudmon KS: Medications for
smoking cessation. West J Med. 176:131–135. 2002.PubMed/NCBI
|
